3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Hodgkin Disease
1
Interventions
fludarabine phosphate
17
Mycophenolic Acid
17
Tacrolimus
15
Peripheral Blood Stem Cell Transplantation
14
Whole-Body Irradiation
13
Cyclophosphamide
12
Cyclosporine
11
Methotrexate
10
Antilymphocyte Serum
10
Busulfan
9
Radiotherapy
6
pembrolizumab
5
Methylprednisolone
5
Alemtuzumab
5
merphos
4
Transplantation
4
Rituximab
4
Melphalan
4
Flow Cytometry
4
Cord Blood Stem Cell Transplantation
4
Bexarotene
4
sargramostim
3
Therapeutics
3
Sirolimus
3
Panobinostat
3
Lenalidomide
3
Gemcitabine
3
Dexamethasone
3
Cyclosporins
3
zanolimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Sezary Syndrome
×
resminostat
×
Clear all
NCT02953301
2024-08-30
RESMAIN
4SC AG
Phase 2
Completed
201 enrolled